Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Top Cited Papers
- 1 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (11), 4251-4258
- https://doi.org/10.1182/blood-2003-07-2365
Abstract
The Leukemia and Lymphoma Molecular Profiling Project recently published results from DNA microarray analyses of 240 diffuse large B-cell lymphomas (DLBCLs). Four gene expression “signatures” were identified as correlated with patient outcome, including the major histocompatibility complex (MHC) class II genes (eg, HLA-DRA) which correlated with better survival. We further analyzed the effects of HLA-DRA on survival and correlated gene expression with protein status and tumor-infiltrating lymphocytes. The 5-year overall survival was 24% in the lowest 10% of HLA-DRA expression, 37% in the 10% to 25% group, 50% in the 25% to 50% group, and 55% for patients in the highest 50%. Further analysis demonstrated that the hazard ratio of death was a nonlinear function of HLA-DRA expression. Adjustment for the International Prognostic Index did not alter the impact of HLA-DRA on survival. Other MHC class II genes were found to predict survival similarly. Microarray HLA-DRA expression correlated with the presence or absence of human leukocyte antigen-DR (HLA-DR) protein in 20 of 22 cases assessed. Fewer tumor-infiltrating CD8+ T cells were detected in MHC class II-negative cases compared with positive cases (2.8% versus 11.0%; P = .001), supporting the hypothesis that loss of tumor immunosurveillance has a devastating effect on patient outcome in DLBCL. (Blood. 2004; 103:4251-4258)Keywords
This publication has 20 references indexed in Scilit:
- Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B‐cell lymphomas of the testis and the central nervous systemGenes, Chromosomes and Cancer, 2002
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresBlood, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Essential Role for Cathepsin S in MHC Class II–Associated Invariant Chain Processing and Peptide LoadingImmunity, 1996
- Step‐function covariate effects in the proportional‐hazards modelThe Canadian Journal of Statistics / La Revue Canadienne de Statistique, 1995
- Suppression of Human Lymphoma Development in the Severe Combined Immune-Deficient Mouse by Imexon TherapyJournal of Immunotherapy, 1993
- Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID miceMolecular and Cellular Probes, 1992
- HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.JCI Insight, 1988
- Bootstrap Methods: Another Look at the JackknifeThe Annals of Statistics, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958